
Redeye Orphan Drugs
April 28 @ 09:00 - 12:00

Abliva will participate at Redeye’s seminar on ‘Drug development in orphan indications.’
CEO Ellen Donnelly will be presenting the company during the event. Follow link below for further details and live webcast.